Dashboard
Company has a low Debt to Equity ratio (avg) at 0 times
Poor long term growth as Net Sales has grown by an annual rate of 10.60% over the last 5 years
Flat results in Sep 25
With ROE of 18.7, it has a Very Expensive valuation with a 6.5 Price to Book Value
Despite the size of the company, domestic mutual funds hold only 0% of the company
Underperformed the market in the last 1 year
Stock DNA
Electrodes & Refractories
INR 688 Cr (Micro Cap)
29.00
36
1.53%
-0.11
18.66%
5.13
Total Returns (Price + Dividend) 
Latest dividend: 19 per share ex-dividend date: Aug-14-2025
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations 2015
01-Apr-2026 | Source : BSEDisclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Resignation by Senior Officer/official
Closure of Trading Window
26-Mar-2026 | Source : BSEIn terms of SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time and Code of Conduct for Prevention of Insider Trading of the Company the trading window shall remain closed for Promoter(s) promoter group Directors and other Designated Person/Employees of the Company from April 1 2026
Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations 2015 On 11-Feb-2026 08:18:06 PM Announcement Under Regulation 30 (LODR)-Resignation Of Chief Financial Officer (CFO)
06-Mar-2026 | Source : BSEThis is with reference to Corporate Announcement submitted by company dated 11-Feb-2026 08:18:06 PM under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 regarding the submission of the resignation letter of the Chief Financial Officer (CFO).
Corporate Actions 
No Upcoming Board Meetings
Morganite Crucible (India) Ltd has declared 380% dividend, ex-date: 14 Aug 25
Morganite Crucible (India) Ltd has announced 5:10 stock split, ex-date: 31 Aug 20
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.0%)
Held by 1 FIIs (0.16%)
Foseco India Limited (75.0%)
Pgim India Equity Growth Opportunities Fund-series I (1.17%)
20.12%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 0.35% vs 7.97% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -36.56% vs 52.17% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 1.46% vs -0.95% in Sep 2024
Growth in half year ended Sep 2025 is -13.44% vs 4.28% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 2.05% vs 2.98% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -18.41% vs 8.21% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 3.73% vs 8.63% in Mar 2024
YoY Growth in year ended Mar 2025 is 17.24% vs 45.72% in Mar 2024